Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Capital Leases (2024 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Capital Leases for 2 consecutive years, with $11000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Capital Leases changed N/A to $11000.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $11000.0, a N/A change, with the full-year FY2024 number at $44000.0, changed N/A from a year prior.
  • Capital Leases was $11000.0 for Q1 2025 at Artiva Biotherapeutics, down from $44000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $106000.0 in Q2 2024 to a low of $11000.0 in Q1 2025.